Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 EUR | -1.60% | 0.00% | -19.34% |
Apr. 29 | Siav S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 03 | ITALY GROWTH WINNERS & LOSERS: Health Italia and Askoll EVA leading the way. | AN |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 51% by 2026.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.34% | 24.05M | - | ||
+9.17% | 3,051B | C+ | ||
+6.91% | 83.97B | B | ||
+3.74% | 76.9B | B+ | ||
-13.73% | 54B | B+ | ||
+25.57% | 48.01B | D+ | ||
-24.95% | 46.47B | B- | ||
+19.54% | 42.04B | D+ | ||
+64.81% | 38.34B | D+ | ||
-14.63% | 24.97B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SIAV Stock
- Ratings Siav S.p.A.